awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Triples
Insights
Schema
BETA
Class frequency
Class hierarchy
SPARQL
Graphs
1
Q55053748-2C97ED14-AD73-405A-8203-A8EB2CA9B7C5
Q55053748-2C97ED14-AD73-405A-8203-A8EB2CA9B7C5
BestRank
Statement
http://www.wikidata.org/entity/statement/Q55053748-2C97ED14-AD73-405A-8203-A8EB2CA9B7C5
Sorafenib in the treatment of thyroid cancer.
P2860
Q55053748-2C97ED14-AD73-405A-8203-A8EB2CA9B7C5
BestRank
Statement
http://www.wikidata.org/entity/statement/Q55053748-2C97ED14-AD73-405A-8203-A8EB2CA9B7C5
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
6f4201798c0fc613be81822fe54759ae460fdb41
P2860
Sorafenib and Mek inhibition is synergistic in medullary thyroid carcinoma in vitro.